Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 3/2000

01-12-2000 | Case report

Gastritis cystica polyposa associated with a gastric stump carcinoma, with special reference to cell kinetics and p53 gene aberrations

Authors: Masahiro Ochiai, Toshiki Matsubara, Li Zhu Zhi, Takahiko Funabiki, Yoichi Sakurai, Shigeru Hasegawa, Hiroki Imazu, Masashi Suganuma

Published in: Gastric Cancer | Issue 3/2000

Login to get access
Metadata
Title
Gastritis cystica polyposa associated with a gastric stump carcinoma, with special reference to cell kinetics and p53 gene aberrations
Authors
Masahiro Ochiai
Toshiki Matsubara
Li Zhu Zhi
Takahiko Funabiki
Yoichi Sakurai
Shigeru Hasegawa
Hiroki Imazu
Masashi Suganuma
Publication date
01-12-2000
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2000
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/PL00011713

Other articles of this Issue 3/2000

Gastric Cancer 3/2000 Go to the issue

Original article

Significance of and problems in adopting response evaluation criteria in solid tumor RECIST for assessing anticancer effects of advanced gastric cancer

Case report

Advanced gastric carcinoma successfully treated with TS-1 as neoadjuvant chemotherapy

Original article

The role of growth patterns, according to Kodama's classification, and lymph node status, as important prognostic factors in early gastric cancer: analysis of 412 cases

Editorial

The challenge of early gastric cancer: the need to optimize microstaging and therapy

Original article

Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer

Original article

Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits